Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 31
Item hits:
Issue DateTitleAuthor(s)
8-Feb-2016In Sickness but Not in Wealth. Field Evidence on Patients’ Risk Preferences in Financial and Health DomainsMiraldo, M; Galizzi, MM; Stravopoulou, C
15-Oct-2018Waiting time at health facilities and social class: Evidence from the Indian caste systemShaikh, M; Miraldo, M; Renner, A-T
1-Jul-2017Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countriesMiraldo, M; Barrenho, E; Smith, P
1-Feb-2019Excess influenza hospital admissions and costs due to the 2009 H1N1 pandemic in EnglandMiraldo, M; Lau, K; Hauck, K; National Institute for Health Research; Pepfar, NIAID, NIMH, NIDA, BMGF, et al
1-May-2019Physician altruism and moral hazard: (no) evidence from Finnish national prescriptions dataCrea, G; Galizzi, M; Linnosmaa, I; Miraldo, M; National Institute for Health and Welfare (THL)
9-Oct-2013The determinants of attrition in drug development: a duration analysisBarrenho, E; Smith, PC; Miraldo, M
16-Dec-2013Doctor-patient differences in risk preferences, and their links to decision-making: a field experimentMiraldo, M; Galizzi, M; Stavropoulou, C
5-Aug-2014Collusion in regulated pluralistic marketsMiraldo, M; Crea, G; Longo, R; Street, A
1-Jul-2017Evaluating the importance of policy amenable factors in explaining influenza vaccination: a cross-sectional multinational studyWheelock, A; Miraldo, M; Thomson, A; Vincent, C; Sevdalis, N, et al
24-Feb-2017Cost-effectiveness and dynamic efficiency: does the solution lie within?Camejo, RR; Miraldo, M; Rutten, F